Skip to main content
SpringerLink
Log in

New oral anticoagulants cost effective in the UK and NL

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Verhoef TI, et al. Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings. American Journal of Cardiovascular Drugs : 18 Oct 2014. Available from: URL: http://doi.org/10.1007/s40256-014-0092-1

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

New oral anticoagulants cost effective in the UK and NL. PharmacoEcon Outcomes News 715, 24 (2014). https://doi.org/10.1007/s40274-014-1682-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1682-5

Search

Navigation